You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,280,959


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,280,959
Title: Metal complexes
Abstract:The invention describes zinc chelated dimeric cell-surface receptor ligands, pharmaceutical compositions containing these compounds, methods of using these compounds as agonist of dimeric cell-surface receptors. Novel processes used in preparing the compounds are also described. Further, the invention describes novel receptor binding moieties of the zinc chelated cell-surface receptor ligands.
Inventor(s): Gleason; John G. (Downingtown, PA), Luengo; Juan I. (Audubon, PA)
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Application Number:09/530,307
Patent Claim Types:
see list of patent claims
Use; Process; Composition; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,280,959

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to fully comprehend its implications and validity. This article will provide a detailed analysis of United States Patent 6,280,959, focusing on its claims, scope, and the relevant patent landscape.

Patent Overview

United States Patent 6,280,959, though not directly provided in the sources, can be analyzed using general principles of patent law and analysis methods.

Claims Analysis

Independent and Dependent Claims

Patent claims are the heart of any patent, defining the scope of the invention. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details[3].

  • Independent Claims: These claims should be concise yet comprehensive, outlining the core elements of the invention. The length and count of independent claims can indicate the breadth of the patent scope.
  • Dependent Claims: These claims narrow down the invention by adding specific limitations or features. A higher number of dependent claims can indicate a more detailed and possibly narrower scope.

Claim Language and Scope

The language used in the claims is critical. Broader claims may face more scrutiny during the examination process and could be more prone to challenges for obviousness or lack of novelty. Narrower claims, on the other hand, are often associated with a higher probability of grant and a shorter examination process[3].

Patent Scope

Metrics for Measuring Scope

Two simple yet effective metrics for measuring patent scope are independent claim length and independent claim count.

  • Independent Claim Length: Longer independent claims often indicate a more complex invention with more specific elements, potentially narrowing the scope.
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope, as it covers more aspects of the invention[3].

Impact on Patent Quality

The debate over patent quality often revolves around the breadth and clarity of patent claims. Patents with overly broad claims can lead to increased licensing and litigation costs, potentially diminishing innovation incentives. Therefore, measuring patent scope accurately is essential for maintaining patent quality[3].

Patent Landscape

Family of Patents

Understanding the family of patents related to the one in question is vital. This includes continuations, continuations-in-part, and divisional applications. Each family member can have different patent terms due to various factors such as Patent Term Adjustments (PTA) or Patent Term Extensions (PTE)[1].

  • Continuations and Continuations-in-Part: These applications can extend the life of the original patent but must be carefully managed to avoid obviousness-type double patenting (ODP) issues.
  • Patent Term Adjustments: PTA can extend the patent term due to USPTO delays during prosecution. However, this does not necessarily extend the term past the date of a terminal disclaimer, which is crucial in avoiding ODP[1].

Obviousness-Type Double Patenting (ODP)

ODP is a critical issue in patent law, aimed at preventing an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA or other factors. This can lead to the invalidation of claims if not properly managed[1].

Prosecution History

Examination Outcomes

The prosecution history of a patent, including the examination outcomes, can provide valuable insights into its validity and scope. This includes first-action allowance rates, progenitor allowance rates, and family allowance rates, which can indicate the complexity and success of the patent application process[4].

  • First-Action Allowance Rate: The proportion of applications allowed without further examination.
  • Progenitor Allowance Rate: The proportion of progenitor applications allowed without any continuation procedure.
  • Family Allowance Rate: The proportion of progenitor applications that produce at least one patent, including outcomes of continuation applications[4].

Industry and Technological Context

The technological field in which the patent resides is also crucial. Patents in highly competitive fields like electrical and electronics, or computers and communications, may face more stringent scrutiny and have different metrics for success compared to those in less competitive fields[4].

Litigation and Enforcement

The enforceability of a patent is closely tied to its scope and claims. Broader claims may be more challenging to enforce due to potential validity issues, while narrower claims may be more defensible but could offer less protection.

Key Takeaways

  • Claims Analysis: Independent and dependent claims define the patent's scope, with broader claims facing more scrutiny.
  • Patent Scope Metrics: Independent claim length and count are key metrics for measuring patent scope.
  • Patent Landscape: Understanding the family of patents and managing ODP issues is crucial.
  • Prosecution History: Examination outcomes provide insights into the patent's validity and scope.
  • Industry Context: The technological field affects the patent's scrutiny and success metrics.
  • Litigation and Enforcement: The enforceability of a patent is tied to its scope and claims.

FAQs

  1. What are the key metrics for measuring patent scope?

    • Independent claim length and independent claim count are two simple yet effective metrics for measuring patent scope[3].
  2. How does obviousness-type double patenting (ODP) affect patent claims?

    • ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA or other factors[1].
  3. What is the significance of Patent Term Adjustments (PTA) in patent law?

    • PTA can extend the patent term due to USPTO delays during prosecution but does not extend the term past the date of a terminal disclaimer, which is crucial in avoiding ODP[1].
  4. How does the prosecution history of a patent impact its validity and scope?

    • The prosecution history, including examination outcomes, provides valuable insights into the patent's validity and scope, indicating the complexity and success of the patent application process[4].
  5. Why is the technological field important in patent analysis?

    • The technological field affects the level of scrutiny and the metrics for success, with highly competitive fields often having more stringent requirements[4].

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. Methods of treating degenerative diseases/injuries - Patent US-2011184035-A1
  3. Patent Claims and Patent Scope - SSRN
  4. What Is the Probability of Receiving a US Patent? - Yale Journal of Law & Technology

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,280,959

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,280,959

PCT Information
PCT FiledOctober 30, 1998PCT Application Number:PCT/US98/23186
PCT Publication Date:May 14, 1999PCT Publication Number: WO99/22732

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.